● Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 73% by 2023.
●
● The group's high margin levels account for strong profits.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
●
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
●
●
Weaknesses
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
●
● The group usually releases earnings worse than estimated.